{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:09:00Z","timestamp":1779232140135,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1016\/j.cellimm.2008.04.001","type":"journal-article","created":{"date-parts":[[2008,5,21]],"date-time":"2008-05-21T14:59:33Z","timestamp":1211381973000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection model"],"prefix":"10.1016","volume":"251","author":[{"given":"Christina C.N.","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Sabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rommel","family":"Tawatao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Fierer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis A.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald G.","family":"Guiney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maripat","family":"Corr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2008.04.001_bib1","first-page":"304","article-title":"Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions","volume":"94","author":"Creticos","year":"2003","journal-title":"Arb. Paul Ehrlich Inst. Bundesamt Sera Impfstoffe Frankf. A. M."},{"key":"10.1016\/j.cellimm.2008.04.001_bib2","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1016\/j.vaccine.2004.01.058","article-title":"Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine","volume":"22","author":"Cooper","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2008.04.001_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/oli.1.1997.7.461","article-title":"Characterization and modulation of immune stimulation by modified oligonucleotides","volume":"7","author":"Boggs","year":"1997","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.cellimm.2008.04.001_bib4","first-page":"421","article-title":"Immune stimulation\u2014a class effect of phosphorothioate oligodeoxynucleotides in rodents","volume":"12","author":"Monteith","year":"1997","journal-title":"Anticancer Drug Des."},{"key":"10.1016\/j.cellimm.2008.04.001_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF01674433","article-title":"Stimulation of in vitro proliferation of murine lymphocytes by synthetic oligodeoxynucleotides","volume":"18","author":"Pisetsky","year":"1993","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cellimm.2008.04.001_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/108729002760220761","article-title":"Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes","volume":"12","author":"Vollmer","year":"2002","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.cellimm.2008.04.001_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1365-2567.2002.01410.x","article-title":"Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo","volume":"106","author":"Dalpke","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2008.04.001_bib8","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1002\/eji.1830271242","article-title":"Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines","volume":"27","author":"Lipford","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib9","doi-asserted-by":"crossref","first-page":"D588","DOI":"10.2741\/Yuen","article-title":"Clinical studies of antisense therapy in cancer","volume":"5","author":"Yuen","year":"2000","journal-title":"Front. Biosci."},{"key":"10.1016\/j.cellimm.2008.04.001_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/ard.1993.3.53","article-title":"Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides","volume":"3","author":"Zhao","year":"1993","journal-title":"Antisense Res. Dev."},{"key":"10.1016\/j.cellimm.2008.04.001_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2008.04.001_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0065-2776(08)60790-7","article-title":"Bacterial CpG DNA activates immune cells to signal infectious danger","volume":"73","author":"Wagner","year":"1999","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1067\/mai.2001.118517","article-title":"The enhanced effect of a hexameric deoxyriboguanosine run conjugation to CpG oligodeoxynucleotides on protection against allergic asthma","volume":"108","author":"Park","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1089\/104303403765701141","article-title":"Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells","volume":"14","author":"Wu","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.cellimm.2008.04.001_bib15","doi-asserted-by":"crossref","first-page":"33071","DOI":"10.1074\/jbc.M311662200","article-title":"Necessity of oligonucleotide aggregation for toll-like receptor 9 activation","volume":"279","author":"Wu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2008.04.001_bib16","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1128\/IAI.73.11.7535-7540.2005","article-title":"MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling","volume":"73","author":"Hughes","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2008.04.001_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/bbrc.2002.6626","article-title":"TNF receptor 1, IL-1 receptor, and iNOS genetic knockout mice are not protected from anthrax infection","volume":"292","author":"Kalns","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2008.04.001_bib18","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/AAC.01050-06","article-title":"Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model","volume":"51","author":"Heine","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cellimm.2008.04.001_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/iai.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to Bacillus anthracis","volume":"51","author":"Welkos","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2008.04.001_bib20","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1128\/IAI.72.8.4801-4809.2004","article-title":"Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility","volume":"72","author":"Lyons","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2008.04.001_bib21","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/IAI.01875-06","article-title":"Murine aerosol challenge model of anthrax","volume":"75","author":"Loving","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2008.04.001_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","article-title":"Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function","volume":"9","author":"Adachi","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2008.04.001_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/75365","article-title":"Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism","volume":"18","author":"Cho","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib24","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/iai.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2008.04.001_bib25","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2003.12.020","article-title":"CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques","volume":"22","author":"Klinman","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2008.04.001_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2958.2001.02695.x","article-title":"Fate of germinated Bacillus anthracis spores in primary murine macrophages","volume":"42","author":"Guidi-Rontani","year":"2001","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1126\/science.273.5273.352","article-title":"Immunostimulatory DNA sequences necessary for effective intradermal gene immunization","volume":"273","author":"Sato","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2008.04.001_bib28","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.4049\/jimmunol.162.4.2368","article-title":"Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis","volume":"162","author":"Sparwasser","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib29","doi-asserted-by":"crossref","first-page":"20563","DOI":"10.1074\/jbc.C300539200","article-title":"Anthrax lethal toxin rapidly activates caspase-1\/ICE and induces extracellular release of interleukin (IL)-1beta and IL-18","volume":"279","author":"Cordoba-Rodriguez","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2008.04.001_bib30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/500468","article-title":"Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival","volume":"193","author":"Cui","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cellimm.2008.04.001_bib31","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.176.3.1776","article-title":"Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens","volume":"176","author":"Duverger","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib32","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1073\/pnas.90.21.10198","article-title":"On the role of macrophages in anthrax","volume":"90","author":"Hanna","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2008.04.001_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1462-5822.2003.00358.x","article-title":"Systemic cytokine response in murine anthrax","volume":"6","author":"Popov","year":"2004","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib34","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1100\/tsw.2002.148","article-title":"Hypothesis: Ran GTPase-based potential therapeutic interventions against lethal microbial infections","volume":"2","author":"Wong","year":"2002","journal-title":"Sci. World J."},{"key":"10.1016\/j.cellimm.2008.04.001_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-3565(25)12269-6","article-title":"Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice","volume":"276","author":"Hnatowich","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellimm.2008.04.001_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0022-3565(25)39459-0","article-title":"Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats","volume":"267","author":"Cossum","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cellimm.2008.04.001_bib37","first-page":"562","article-title":"Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides","volume":"2","author":"Geary","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.cellimm.2008.04.001_bib38","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib39","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.addr.2005.01.028","article-title":"Molecular basis for improved anthrax vaccines","volume":"57","author":"Brey","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cellimm.2008.04.001_bib40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2008.04.001_bib41","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/j.vaccine.2005.08.025","article-title":"Comparison of the immunological memory after DNA vaccination and protein vaccination against anthrax in sheep","volume":"24","author":"Hahn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2008.04.001_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijmm.2003.12.002","article-title":"Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination","volume":"294","author":"Hahn","year":"2004","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1513\/pats.200701-021AW","article-title":"Antiinfective applications of toll-like receptor 9 agonists","volume":"4","author":"Krieg","year":"2007","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.cellimm.2008.04.001_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/14760584.5.3.365","article-title":"CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine","volume":"5","author":"Klinman","year":"2006","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.cellimm.2008.04.001_bib45","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/IAI.73.2.828-833.2005","article-title":"CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine","volume":"73","author":"Xie","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2008.04.001_bib46","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.4049\/jimmunol.173.8.5148","article-title":"CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection","volume":"173","author":"Deng","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib47","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1128\/IAI.69.10.6156-6164.2001","article-title":"Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase","volume":"69","author":"Hayashi","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2008.04.001_bib48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4049\/jimmunol.174.2.777","article-title":"CpG oligodeoxynucleotides enhance neonatal resistance to Listeria infection","volume":"174","author":"Ito","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib49","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00002371-200411000-00006","article-title":"Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist","volume":"27","author":"Krieg","year":"2004","journal-title":"J. Immunother."},{"key":"10.1016\/j.cellimm.2008.04.001_bib50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1574-695X.2006.00096.x","article-title":"Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages","volume":"47","author":"Sabet","year":"2006","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib51","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.jaci.2005.08.048","article-title":"Innate immunity for biodefense: a strategy whose time has come","volume":"116","author":"Amlie-Lefond","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2008.04.001_bib52","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1073\/pnas.0611624104","article-title":"Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand","volume":"104","author":"Wu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874908000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874908000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:42:29Z","timestamp":1757803349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874908000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"alternative-id":["S0008874908000695"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2008.04.001","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection model","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2008.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}